Interplay between key proteins could serve as a target for cancer treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 11-Jul-2025 19:10 ET (11-Jul-2025 23:10 GMT/UTC)
In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a surprising phenomenon in which high doses of radiation cause growth in existing metastatic tumors that weren’t directly treated with radiation.
The United States-based National Comprehensive Cancer Network is among groups from up to 75 countries taking part in the Cancer Planners Forum in Geneva, Switzerland.
Researchers of the Cancer Epigenetics group at the Josep Carreras Leukaemia Research Institute have discovered that patients with Burkitt lymphoma — a common paediatric tumour in equatorial African countries and Latin America — can be classified into two main groups based on their epigenetic signature. The study, a high-level international collaboration co-led by Dr Manel Esteller, has demonstrated that one group, HypoBL, has a milder course of the disease, whereas the other, HyperBL, is associated with early relapses and shorter survival.
New device can give peace of mind and reduce anxiety for breastfeeding moms. It uses bioimpedance, which is currently used to measure body fat, and streams clinical-grade data to a smartphone or tablet in real time. Developed by physicians and engineers, device was tested by new moms. Technology could particularly benefit fragile babies in the NICU, who have precise nutritional needs.
A new study in the European Heart Journal shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not have a better prognosis than those diagnosed earlier. The study, conducted by researchers at Karolinska Institutet in Sweden, points to smoking, poor glucose control and obesity as the main risk factors.